thoracic hemivertebra as in child F H has also been reported in these children with a severe external ear malformation (Nair & Mathew 1963 ). Dysphagia as in child K K may be present in Mobius syndrome.
The distinguishing feature of the cardiofacial syndrome is the localization of the facial paralysis. The importance of recognizing this paralysis at birth is that it may be associated with cardiac malformation. Essential Thrombocyth&emia in Childhood Susan E LumleyI MRCP DCH (for B W Powell FRCP) (Peterborough District Hospital, Peterborough, Northamptonshire) Girl born 30.4.56 History: Known to have had the condition for at least seven years. First seen in 1962 complaining of recurrent frontal headaches, often severe, and abdominal pains frequently localized to the left hypochondrium. She had a tendency to bruise easily and in 1966 she had bleeding from tooth sockets for over 24 hours. In 1967 she bled for two hours from a finger prick but there have been no episodes of more severe or prolonged bleeding and she has never required a blood transfusion. Her general health has been otherwise good and she is an active person and good at cross-country running. There have been no other illnesses of significance and no family history of a hemorrhagic diathesis. On examination: Apparently healthy with several telangiectases on forehead and cheeks (which have subsequently disappeared) and several bruises on limbs. Firm non-tender enlargement of spleen 8 cm below costal margin (this remains unchanged) but there has never been any hepatic enlargement. The patient was, and has remained, normotensive. Optic fundi normal. There have been no other abnormal findings. Investigations (February 1965; these findings are representative of her blood picture since): Platelets I Present address: Royal Liverpool Children's Hospital, Liverpool 7 1,345,000/mm3; Hb 16 g/100 ml; WBC 17,700/ mm3 (has frequently been above 10,000/mm3), polys. 64%, lymphos. 27 %, monos. 4%, eosinos. 5%. RBC 6,510,000/mm3, PCV 42%, MCHC 330%. Blood film: slight anisocytosis; numerous platelets with occasional giant platelets. Serum proteins 7 g/100 ml (normal electrophoretic strip). Leukocyte alkaline phosphatase score 49. Clotting time 7 5 min; bleeding time 2 min. Quick's one-stage prothrombin time 15 sec (control 15 sec). Prothrombin consumption index <10%. Recalcification time 87 sec. Urea clot solubility test normal. AHG assay: AHG 50 % of pooled normal plasma.
Platelet function tests (7.3.69): Poor clot retraction; deficient Factor 3 release; incomplete aggregation after contact with ADP. The platelet count was consistently above 800,000/mm3, and frequently above 1,000,000/mm3, with some giant forms. Megakaryocytic fragments and bizarre forms may be found in the peripheral blood. Treatment and progress: Busulphan, 2 mg daily, was given initially on 3.4.69 and this was doubled after eighteen days and given for three months. There was a gradual and consistent fall in the platelet count which reached its lowest level of 210,000/mm3 three months after treatment was discontinued. Thereafter the platelet count gradually rose again, the latest value being 450,000/mm3 on 9.2.70.
Discussion
Essential thrombocythemia is an extremely rare condition in childhood, only three other cases having so far been reported (Spach et al. 1963 , Thieffry et al. 1957 , Ozer et al. 1960 ). The condition is defined as being a three-fold increase in platelets with megakaryocytic hyperplasia of the bone marrow, in the absence of disease leading to an increase in platelets. Five criteria were suggested for the diagnosis by Ozer et al. (1960) .
Essential thrombocythmemia forms part of the spectrum of myeloproliferative disorders being very closely related and sometimes developing into myeloid leukwmia and polycythevmia vera. It is essentially a panmyelosis in which elevation of the platelets predominates.
Bleeding and coagulation studies on these patients are usually normal and yet there is frequently a hkmorrhagic diathesis. Bleeding occurs usually into the skin and mucous membranes and post-extraction bleeding can be particularly troublesome. Epistaxes and massive gastrointestinal hmmorrhages can occur and are sometimes the main feature of the disease. However, although platelets from these patients have been used with efficacy in patients with thrombocytopenia, slight defects in platelet function tests are usually present as in this patient. It was originally felt that the excess number of platelets interfered with formation and action of thromboplastins, so resulting in hemorrhage. It is now felt that an actual defect of the platelet surface is responsible.
The Hb and PCV are both usually raised but values of not more than 18 g/100 ml and 54% respectively are usually found. Similarly elevated red and white cell counts are characteristic, but values should not exceed 6,000,000/mm3 and 50,000/mms respectively (Ozer et a!. 1960) . Eosinophilia and basophilia are frequently present. The bone marrow characteristically shows a generalized hyperplasia, particularly of the megakaryocytes with sheets of platelets.
Other characteristic features of the condition are headaches, parmsthesie, hepatosplenomegaly and occasionally hypertension; frequently a hypochromic, microcytic anemia is present as a direct result of repeated hemorrhage. Rarely a hmmolytic anemia results from hypersplenism.
The first child to be described with thrombocythmmia presented with a hemiplegia, transient loss of vision and evidence of a myocardial infarction. Thromboses, arterial or venous, constitute the main hazard of this condition. Deep or superficial veins may be involved and there is an obvious risk of pulmonary infarction. There may be thrombosis in the femoral, carotid, coronary or peripheral arteries, and adrenal infarcts, recurrent pancreatitis and steatorrh4ea have all been ascribed to thrombocythemia.
Because of the tremendous risks of thrombohiemorrhagic phenomena, therapy to reduce the platelet count in our patient was felt to beindicated. Busulphan was selected but there are significant risks. Pancytopenia, aplastic anemia, hmmolytic anemia, pigmentation, amenorrhoea, gastrointestinal upsets, cataracts, diffuse interstitial pulmonary fibrosis and alopecia have all been described following its use, though only the latter was manifest in our patient.
She has felt very much better since the course of busulphan and her headaches are now mild and infrequent. The patient of Spach et al. (1963) , a girl of 8, was alive and well without treatment eight years later, and Thieffry et al. described a girl of 12 in 1957 who was well ten months later. Ozer's patient (Ozer et al. 1960) , aged 12, died after three years with myelocytic leukaemia. Postscript: Our patient was well when last seen (10.11.70), but the platelet count had increased to 622,000/mm3.
